Special Issue "New Insight of Cell Mechanisms and Therapeutic Approaches in Rheumatic Diseases"

A special issue of Biology (ISSN 2079-7737). This special issue belongs to the section "Medical Biology".

Deadline for manuscript submissions: 31 October 2022 | Viewed by 425

Special Issue Editors

Dr. Cristina Antinozzi
E-Mail Website
Guest Editor
Department of Human Motor and Health Sciences, University of Rome "Foro Italico", 00135 Rome, Italy
Interests: cellular biology; cell metabolism; rheumatic diseases; systemic sclerosis; hormones; PDE5 inhibitors
Prof. Dr. Ivan Dimauro
E-Mail Website
Guest Editor
Department of Human Motor and Health Sciences, University of Rome "Foro Italico", 00135 Rome, Italy
Interests: exercise; redox homeostasis; systemic sclerosis; cellular biology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Rheumatic diseases refer to a group of autoimmune and inflammatory disorders affecting joints, bones, cartilage, tendons, ligaments and muscles. These disorders affect an important fraction of the population and lead to increased health medical costs, disability and early mortality. The etiologies are complex and generally not fully understood, making the study of pathogenic mechanisms and the pharmacological approaches in these diseases a great challenge for researchers. Better characterization and understanding of the cellular and molecular events driving these disorders is critical in order to prevent the established diseases or inhibit their development, growth and worsening.

The aim of this issue “New insight of cell mechanism and therapeutic approaches in rheumatic diseases” is highlight promising researches focusing the pathogenesis, management and prevention of rheumatic diseases, including but not limited to vasculopathies, scleroderma, osteoporosis, polymyalgia rheumatica (PMR), as well as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). We welcome different types of manuscript submissions, such as original articles, narrative reviews, systematic reviews, as well as meta-analyses concerning any aspect of cellular and molecular mechanism, diagnosis and treatment regarding the main rheumatic disorders, to provide a state-of-the-art overview of this issue.

Dr. Cristina Antinozzi
Prof. Dr. Ivan Dimauro
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • autoimmune diseases
  • rheumatic diseases
  • pharmacological approaches
  • cell metabolism
  • molecular mechanisms
  • inflammation
  • physical therapies
  • biomarkers
  • disease prevention
  • antibodies

Published Papers

This special issue is now open for submission.
Back to TopTop